ABIN1512875

antibody from antibodies-online

Targeting: MAPK3 ERK1, p44erk1, p44mapk, PRKM3

Western blot (Supportive data in Antibodypedia)

Immunocytochemistry (Supportive data in Antibodypedia)

Immunohistochemistry (Recommended by provider)

Antibody Data

Product number

ABIN1512875

Provider

antibodies-online

Product name

anti-Mitogen-Activated Protein Kinase 3 (MAPK3) (N-Term) antibody

Antibody type

Polyclonal

Antigen

N term -peptide of human ERK1

Description

Affinity purification  

Reactivity

Human, Mouse, Rat

Host

Rabbit

Epitope

N-Term

Isotype

IgG

Vial size

100 μg

Storage

-20°C/-80°C

Handling

Avoid freeze / thaw cycles

References

Submitted references

KAT5 silencing induces apoptosis of GBC-SD cells through p38MAPK-mediated upregulation of cleaved Casp9.

Feng FL, Yu Y, Liu C, Zhang BH, Cheng QB, Li B, Tan WF, Luo XJ, Jiang XQ
International journal of clinical and experimental pathology 2014;7(1):80-91

---

Activation of AKT/ERK confers non-small cell lung cancer cells resistance to vinorelbine.

Fan DP, Zhang YM, Hu XC, Li JJ, Zhang W
International journal of clinical and experimental pathology 2014;7(1):134-43

---

RAF1-MEK1-ERK/AKT axis may confer NSCLC cell lines resistance to erlotinib.

Xu ZH, Hang JB, Hu JA, Gao BL
International journal of clinical and experimental pathology 2013;6(8):1493-504

Western blot

Supportive validation

Submitted by

antibodies-online (provider)

Main image

Experimental details

Western blot analysis of extracts of various cell lines, using MAPK3 antibody.

Immunocytochemistry

Supportive validation

Submitted by

antibodies-online (provider)

Main image

Experimental details

Image(s): Immunofluorescence